Copyright
©The Author(s) 2026.
World J Clin Cases. Jan 16, 2026; 14(2): 114762
Published online Jan 16, 2026. doi: 10.12998/wjcc.v14.i2.114762
Published online Jan 16, 2026. doi: 10.12998/wjcc.v14.i2.114762
Table 1 Full hemogram findings
| Parameter | Units | Results | Reference range |
| WBC | × 109/L | 4.69 | 4.0-10.8 |
| Neutrophils | % | 32.8 | 40-75 |
| Lymphocytes | % | 59.9 | 21-40 |
| Monocytes | % | 5.4 | 3-12 |
| Eosinophils | % | 1.4 | 0.5-5 |
| Basophils | % | 0.5 | 0.5-5 |
| RBC | × 109/L | 4.56 | 4.7-6.1 |
| HB | g/dL | 12.6 | 11.2-16.0 |
| HCT | % | 38.3 | 37.0-47.0 |
| MCV | fL | 83.9 | 76.0-100.0 |
| MCH | Pg | 27.5 | 27.0-31.0 |
| MCHC | g/dL | 32.8 | 32.0-36.0 |
| RDW-C | % | 13.8 | 11.5-14.5 |
| Platelets count | × 109/L | 202 | 160.0-450.0 |
| MPV | fL | 9.1 | 6.5-12.0 |
| PDW | % | 15.9 | 9.0-17.0 |
| PCT | % | 0.228 | 0.108-0.282 |
Table 2 Liver function test findings
| Parameter | Units | Results | Reference range |
| Albumin | g/L | 36.33 | 35-52 |
| ALP | U/L | 38.1 | 35-104 |
| ALT | U/L | 34.2 | 0-40 |
| AST | U/L | 33.9 | 0-32 |
| GGT | U/L | 6.7 | 5-36 |
| Total protein | g/L | 68.4 | 66-87 |
Table 3 Urea, creatinine, and electrolytes findings
| Parameter | Units | Results | Reference range |
| Chloride | mmol/L | 101.5 | 95-107 |
| Creatinine | µmol/L | 68 | 44-80 |
| Potassium | mmol/L | 3.86 | 3.5-5.1 |
| Sodium | mmol/L | 135.7 | 135-145 |
| Urea | mmol/L | 4.64 | 2.76-8.07 |
Table 4 C-reactive protein findings
| Parameter | Units | Results | Reference range |
| CRP | mg/L | 75.2 | 0-10.0 |
Table 5 Literature review
| Ref. | Country | Trimester | Management | Maternal outcome | Fetal outcome |
| Najafian et al[2], 2020 | Iran | All | Antivenom administered 6-12 hours post-sting; supportive care | Stable | 11% neonatal complications; Apgar < 8 in 11.3% of preterm births |
| Ben Nasr et al[8], 2009 | Tunisia | All | Supportive care; antivenom use recommended | Stable | Risk of preterm birth, fetal anomalies, and long-term developmental issues |
| Kaplanoglu and Helvaci[6], 2015 | Turkey | All | Symptomatic care (no antivenom) | Stable | All live births |
| Leibenson et al[7], 2009 | Israel | 3rd | Supportive care | Stable | Stillbirth |
| Brown et al[10], 2013 | Review | All | Supportive care; antivenom for severe cases | Optimal outcomes with early intervention | Improved fetal outcomes with maternal stabilisation |
| Present case, 2025 | Kenya | 3rd | Early antivenom; multidisciplinary care | Full recovery | Healthy neonate |
Table 6 Key considerations in scorpion envenomation during pregnancy
| Aspect | Clinical implications |
| Pathophysiology | Catecholamine-induced uteroplacental vasoconstriction leading to fetal hypoxia |
| Maternal symptoms | Autonomic storm (hypertension, tachycardia), local pain, potential for severe complications (eclampsia, myocarditis) |
| Fetal effects | Tachycardia, distress, potential preterm labor or demise in severe cases |
| Critical management | Prompt antivenom administration, multidisciplinary care, and continuous fetal monitoring |
| Resource-limited challenges | Antivenom accessibility, harmful traditional practices, and delayed presentation |
- Citation: Omullo FP. Successful management of third-trimester scorpion envenomation (Parabuthus maximus) in a resource-limited setting: A case report. World J Clin Cases 2026; 14(2): 114762
- URL: https://www.wjgnet.com/2307-8960/full/v14/i2/114762.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i2.114762
